Join SelectScience® CEO, Kerry Parker, as she speaks to Dr. Mimi Roy who is working at the cutting edge of developing gene therapies in rare diseases. During this podcast discussion, Roy shares how gene therapies and viral vectors work and why AI and mass spectrometry are accelerating science in this field. Roy also discusses her perspectives on time management, her outlook on teamwork, and how the future of science is a multidisciplinary and human endeavour. After beginning her academic career in India, Roy embarked on a journey that led her to Sydney, Australia, and eventually the United States, where she pursued her Ph.D. in Chemistry at Princeton University then a postdoctoral research position at the Scripps Research Institute. Roy then discovered the world of start-ups and biopharmaceuticals and never looked back.
","author_name":"SelectScience"}